secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001193125-26-067858
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q4 revenue $382M (+17% YoY); net income $11.7M; $100M buyback; Chairman transition
--------------------------------------------------------------------------------

- Q4 revenue $382.2M (+17% YoY); full-year revenue $1.42B (+14% YoY).
- Q4 net income $11.7M vs loss $7.1M; full-year net income $9.7M vs loss $57.4M.
- Adjusted EBITDA Q4 $48.8M (+49% YoY); full-year $157.7M (+32% YoY).
- 2026 guidance: revenue $1.615B-$1.655B; Adjusted EBITDA $185M-$205M.
- Board approved $100M share repurchase; Kenneth Burdick transitions to non-executive Chairman effective Mar 16, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000119312526067858/0001193125-26-067858-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000119312526067858/lfst-20260225.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-067858

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer